VTV THERAPEUTICS INC. overview

vTv Therapeutics Announces 2021 fourth Quarter and Full Year Financial Results and Provides Corporate Update PR Newswire HIGH POINT, N.C., March 29, 2022 HIGH POINT, N.C. , March 29, 2022 /PRNewswire/ -- vTv Therapeutics Inc. (Nasdaq: VTVT) today reported financial results for the fourth quarter and year ended December 31, 2021 , and provided an update on the progress of its clinical programs. "I am dedicated to the long-term growth and development of the Company and look forward to working with...

vTv Therapeutics Announces Deepa Prasad as New President and CEO PR Newswire HIGH POINT, N.C., Oct. 20, 2021 HIGH POINT, N.C. , Oct. 20, 2021 /PRNewswire/ -- vTv Therapeutics Inc. (Nasdaq: VTVT) a clinical-stage biopharmaceutical company focused on the development of orally administered treatments for type 1 diabetes and psoriasis, today announced that Deepa Prasad will lead the company as President and Chief Executive Officer, effective immediately. Stephen L. Holcombe who previously served as...

...

Thinking about buying stock in Zomedica, vTv Therapeutics, Canaan, SOS, or Palantir Technologies? PR Newswire NEW YORK, April 13, 2021 NEW YORK , April 13, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for ZOM, VTVT, CAN, SOS, and PLTR. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link. ZOM:...

...

...

...

...